G. Michael Flannigan

Author

Also Known As

G M Flannigan, G Michael Flannigan, G. M. FLANNIGAN, G. M. Flannigan, G. Michael Flannigan, G.M Flannigan, G.M. Flannigan, Gerrard Flannigan

Publications

353

Citations

H-Index

Concepts

All Affiliations

Luton and Dunstable Hospital University of Bradford Middlesex Hospital Hammersmith Hospital Bradford Royal Infirmary

About

G. Michael Flannigan is an author at Luton and Dunstable Hospital specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	173
2	Public Health	2	2	20
3	Health Sciences	1	1	27
4	Social Sciences	1	1	10
5	Anesthesia	1	1	27

G. Michael Flannigan

Publications

323

Citations

H-Index

Page 1

	Year	Citations
Rigid versus Flexible Cystoscopy A Controlled Trial of Patient Tolerance G. Michael Flannigan, J. Gelister, J. Gareth Noble, British Journal of Urology	1988	61
A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9 Guzanfar A. Choudry, P A Hamilton Stewart, John A. Double, British Journal of Cancer	2001	52
Randomised, Placebo Controlled, Double Blind Study of Alfuzosin SR in Patients Undergoing Trial without Catheter Following Acute Urinary Retention Tariq Shah, Victor Palit, Shekhar Biyani, European Urology Urological ResearchUrologyDouble Blind StudyVoiding DysfunctionAlfuzosin Sr	2002	41
Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy Saurajyoti Basu, John E. Brown, G. Michael Flannigan, International Journal of Cancer	2004	27
lndomethacin—an Alternative to Pethidine in Ureteric Colic G. Michael Flannigan, RANDALL CLIFFORD, R.A. Carver, British Journal of Urology Pain MedicineGastrointestinal PharmacologyPharmacotherapyDrug ResistancePain Management	1983	27
Telomerase activity in malignant and benign bladder conditions. M P Mayfield, Tariq Shah, G. Michael Flannigan, International Journal of Molecular Medicine Urological ResearchUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	1998	22
Indomethacin—An Alternative to Pethidine in Ureteric Colic G. Michael Flannigan, RANDALL CLIFFORD, R.A. Carver, The Journal of Urology Urological ResearchUrologyAntibioticsMedicineInformation	1983	18
Appendicitis Presenting With Painless Hematuria G. Michael Flannigan, J. M. TOWLER The Journal of Urology UrologyAcute AppendicitisNephritic SyndromeOperative ManagementMicroscopic Hematuria	1983	16
Simultaneous presentation of papillary carcinoma of thyroid in a father and son G. Michael Flannigan, RANDALL CLIFFORD, Marc Winslet, British journal of surgery Surgical OncologySimultaneous PresentationPathologyEndocrine OncologyOncology	1983	15
NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C. Saurajyoti Basu, John E. Brown, G. Michael Flannigan, International Journal of Oncology Tumor BiologyUrological ResearchUrologyUrologic Cancer EpidemiologyGenitourinary Cancer	2004	14

Page 1